Participants will be randomized ( in a @:@ ratio ) to receive oral granulated Chinese herbal medicine YXBCM@ plus topical calcipotriol @ % or oral YXBCM@ placebo plus topical calcipotriol @ % treatment for @ weeks , with a @-week follow-up phase .